Climate Change Data

Mallinckrodt plc

Climate Impact & Sustainability Data (2019, 2022, 2023)

Reporting Period: 2019

Environmental Metrics

Total Carbon Emissions:191,020 tCO2e/year
Carbon Intensity:60.4 tCO2e per Million USD (GhG Scope 1 + 2 per sales)

ESG Focus Areas

  • Improve the lives of underserved patients with severe and critical conditions
  • Foster a culture of diversity, equality and inclusion
  • Strengthen the communities where our employees live and work
  • Conduct our business with integrity and transparency
  • Responsibly manage our ecological footprint

Environmental Achievements

  • Reduced energy usage at U.S. corporate shared services site in Hazelwood, Mo. through heating and cooling upgrades, innovative controls and heat recovery systems
  • Eliminated a coal-fired burner at another major facility, improving energy efficiency and reducing greenhouse gas emissions

Social Achievements

  • Improved racial diversity in the organization by nearly 6% in less than a year, with the greatest impact in senior roles
  • Launched a thoughtful and intentional recruitment and retention strategy focused on diversity
  • Donated over $6.4 million in charitable grants to patient advocacy organizations
  • Supported over 100 patient education initiatives
  • Worked with more than 20 professional associations and societies to advance scientific knowledge to improve health outcomes
  • Established an advocacy advisory board in 2019
  • Instituted a volunteer leave program to give medically trained employees paid time off to treat or care for patients with COVID-19
  • Donated 54,000+ pieces of PPE and 3 ventilators worldwide in response to COVID-19
  • Donated 12,000+ gallons of hand sanitizer to emergency operation centers and opioid treatment programs in the U.S. in response to COVID-19
  • Donated $400K+ to support community response to COVID-19
  • Supported clinical studies to evaluate the role of nitric oxide as a treatment for patients infected with COVID-19

Governance Achievements

  • Maintained a confidential 24-hour ethics and compliance reporting hotline with a strict, company-wide policy of non-retaliation
  • Regular compliance training programs and frequent dialogue between management and employees
  • Reviewed and updated Compliance Program policies and procedures regularly

Climate Goals & Targets

Short-term Goals:
  • Continue to gather data and analyze enterprise energy usage and waste emissions
  • Incorporate select Scope 3 GhG emissions data capture to allow future consideration for Corporate Value Chain and Product Life Cycle emission methods
  • Extend environmental sustainability expectations into our supplier networks, including contract manufacturing and/or material suppliers
  • Identify opportunities to reduce our environmental footprint and develop measurable goals for 2021

Environmental Challenges

  • Opioid abuse and addiction
  • Maintaining global compliance across a myriad of highly complex regulatory and legal requirements
Mitigation Strategies
  • Comprehensive and multifaceted approach that supports the safe use, storage and disposal of prescription drugs
  • Collaboration with policymakers, law enforcement and other stakeholders
  • Industry-leading anti-diversion program
  • Regular compliance training programs and frequent dialogue between management and employees
  • Independent compliance functions managed separately from manufacturing and commercial operations

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct
  • PSCI Principles for Responsible Supply Chain Management

Climate-Related Risks & Opportunities

Awards & Recognition

  • Human Rights Campaign’s Best Places to Work for LGBTQ Equality (2017–2020)
  • PRISM International Top 10 Diversity Councils (3 consecutive years)
  • KeepWell Mark™ (Mallinckrodt Ireland)
  • Manufacturing Leadership Awards (2 Specialty Generics sites)
  • Cardinal Health supply chain excellence (3 consecutive years)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:171,898 tCO2e/year
Scope 1 Emissions:89,551 tCO2e/year
Scope 2 Emissions:82,347 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:470,676 MWh/year
Water Consumption:1,163,209 m3/year
Waste Generated:4,953 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Global headquarters in Dublin, Ireland sourced 100% renewable energy.
  • Numerous facilities upgraded to more energy-efficient equipment and LED lights.
  • Electric vehicle charging stations installed at four corporate offices.
  • Raleigh, NC facility uses landfill gas (22% of fuel) and process waste as fuel.
  • 16% of electricity used at Sanda plant and Kobe laboratory in Japan came from renewable sources.
  • St. Louis, MO manufacturing facility reduced water usage by more than 50% since 2016.
  • 88% of hazardous waste generated was recycled or reclaimed.
  • Global headquarters and plant in Dublin, Ireland recycled or reclaimed over 50% of non-hazardous waste.

Social Achievements

  • Received U.S. FDA approval of Terlivaz® (terlipressin) for injection.
  • Formalized governance for ESG program with Board-level oversight and a new ESG Steering Committee.
  • Strengthened Integrity & Compliance program with a refreshed Code of Conduct (99% employee completion rate).
  • Advanced diversity, equity, and inclusion with appointments of women, POC, and LGBTQ+ individuals to executive and board positions.
  • Enhanced mental health resources and provided greater work flexibility.
  • Groundbreaking for manufacturing expansion at Greenville, Illinois site.
  • Supported patient-centric charities and communities (6th annual Global Month of Service).
  • $938.7 million worth of free medicine donated through the Acthar patient assistance program.
  • Completed 18 research initiatives and delivered 27 publications in HEOR.

Governance Achievements

  • Established Board-level oversight and an ESG Steering Committee.
  • Developed a Sustainability Framework.
  • Launched a refreshed Code of Conduct and Integrity Culture campaign.
  • Entered into a five-year Corporate Integrity Agreement with the U.S. Department of Health and Human Services Office of Inspector General.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • 2022 Industrial Pretreatment Gold Award (St. Louis facility)
  • 2022 Environmental Stewardship Award (Raleigh facility)
  • Best Places to Work for LGBTQ+ Equality (HRC Foundation)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:162,999 tCO2e/year
Scope 1 Emissions:89,052 tCO2e/year
Scope 2 Emissions:73,947 tCO2e/year (location-based), 74,164 tCO2e/year (market-based)
Renewable Energy Share:100% at Dublin headquarters, up to 17% at Raleigh site
Total Energy Consumption:612,609 MWh/year
Water Consumption:1,232,748 m3/year (withdrawal), 785,124 m3/year (discharge)
Waste Generated:5,945 tons/year (hazardous), 4,847 tons/year (non-hazardous)

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Improved CDP Climate Change and Water Security scores for Specialty Generics
  • Two largest U.S. manufacturing sites recognized for compliance and environmental excellence in wastewater management
  • Dublin headquarters sourced 100% renewable electricity

Social Achievements

  • Received NORD Industry Innovator Award for TERLIVAZ approval
  • Launched three generic products contributing to more affordable healthcare
  • Japan approved reimbursement for CELLEX ECP system
  • Received Human Rights Campaign’s Equality 100 and Forbes Best Employers for Veterans designations
  • 21% of addressable spend allocated to small and diverse suppliers
  • $1B+ worth of free medicine donated through Patient Assistance Program

Governance Achievements

  • Implemented ESG data management platform (Workiva)
  • 100% of active employees trained on Mallinckrodt Code of Conduct
  • Presented sustainability strategy to Mallinckrodt’s Board of Directors

Climate Goals & Targets

Environmental Challenges

  • Reducing carbon footprint and environmental impact
  • Addressing water-related challenges
  • Managing waste effectively
Mitigation Strategies
  • Developed decarbonization and environmental improvement program
  • Established comprehensive energy and emission tracking process
  • Joined Schneider Electric’s Energize program
  • Integrated sustainability into strategic and risk management process
  • Implemented water management and consumption initiatives
  • Waste-to-energy programs
  • Digital innovation to reduce waste

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct
  • PSCI Principles
  • Conflict Minerals Policy
  • Supplier diversity program

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Greenhouse Gas Protocol

Sustainable Products & Innovation

  • INOmax EVOLVE DS Delivery System
  • INOmax Mini-Cylinder

Awards & Recognition

  • NORD Industry Innovator Award
  • Human Rights Campaign’s Equality 100
  • Forbes Best Employers for Veterans